Latest period
1.75B
YoY change
-0.1%
5Y CAGR
-0.4%
Peak year (1986)
1.86B
Latest annual
1.75B
Shares Outstanding history chart for Abbott Laboratories (ABT) from 1985 to 2025
Latest: 1.75B
Shares Outstanding growth chart for Abbott Laboratories (ABT) from 1985 to 2025
Latest: -0.1%
Shares Outstanding history table for Abbott Laboratories (ABT) from 1985 to 2025
| 2025 | 1.75B | -0.1% | -1.00M | ||
| 2024 | 1.75B | -0.1% | -1.00M | ||
| 2023 | 1.75B | -0.9% | -15.00M | ||
| 2022 | 1.76B | -1.4% | -25.00M | ||
| 2021 | 1.79B | +0.2% | +3.00M | ||
| 2020 | 1.79B | +0.3% | +5.00M | ||
| 2019 | 1.78B | +0.6% | +11.00M | ||
| 2018 | 1.77B | +1.2% | +21.00M | ||
| 2017 | 1.75B | +17.9% | +266.00M | ||
| 2016 | 1.48B | -1.5% | -23.00M | ||
| 2015 | 1.51B | -1.4% | -21.00M | ||
| 2014 | 1.53B | -3.0% | -47.00M | ||
| 2013 | 1.57B | -1.1% | -18.00M | ||
| 2012 | 1.59B | +1.4% | +21.62M | ||
| 2011 | 1.57B | +0.9% | +14.38M | ||
| 2010 | 1.56B | +0.1% | +1.00M | ||
| 2009 | 1.55B | -0.4% | -5.75M | ||
| 2008 | 1.56B | +0.0% | +696,000 | ||
| 2007 | 1.56B | +1.5% | +23.33M | ||
| 2006 | 1.54B | -1.8% | -27.38M | ||
| 2005 | 1.56B | -0.4% | -6.51M | ||
| 2004 | 1.57B | -0.1% | -1.26M | ||
| 2003 | 1.57B | -0.1% | -1.42M | ||
| 2002 | 1.57B | +0.5% | +7.24M | ||
| 2001 | 1.57B | +0.0% | +471,505 | ||
| 2000 | 1.57B | +0.5% | +7.92M | ||
| 1999 | 1.56B | -0.2% | -3.30M | ||
| 1998 | 1.56B | -0.9% | -14.12M | ||
| 1997 | 1.58B | -0.4% | -6.44M | ||
| 1996 | 1.58B | -0.8% | -13.13M | ||
| 1995 | 1.59B | -1.8% | -29.83M | ||
| 1994 | 1.62B | -2.0% | -33.50M | ||
| 1993 | 1.66B | -1.0% | -16.48M | ||
| 1992 | 1.67B | -1.6% | -26.79M | ||
| 1991 | 1.70B | -1.4% | -23.39M | ||
| 1990 | 1.72B | -1.7% | -30.05M | ||
| 1989 | 1.75B | -2.0% | -35.78M | ||
| 1988 | 1.79B | -0.9% | -16.95M | ||
| 1987 | 1.81B | -3.0% | -56.36M | ||
| 1986 | 1.86B | +0.1% | +2.59M | ||
| 1985 | 1.86B | — | — |
- 20251.75B-0.1%
- 20241.75B-0.1%
- 20231.75B-0.9%
- 20221.76B-1.4%
- 20211.79B+0.2%
- 20201.79B+0.3%
- 20191.78B+0.6%
- 20181.77B+1.2%
- 20171.75B+17.9%
- 20161.48B-1.5%
- 20151.51B-1.4%
- 20141.53B-3.0%
- 20131.57B-1.1%
- 20121.59B+1.4%
- 20111.57B+0.9%
- 20101.56B+0.1%
- 20091.55B-0.4%
- 20081.56B+0.0%
- 20071.56B+1.5%
- 20061.54B-1.8%
- 20051.56B-0.4%
- 20041.57B-0.1%
- 20031.57B-0.1%
- 20021.57B+0.5%
- 20011.57B+0.0%
- 20001.57B+0.5%
- 19991.56B-0.2%
- 19981.56B-0.9%
- 19971.58B-0.4%
- 19961.58B-0.8%
- 19951.59B-1.8%
- 19941.62B-2.0%
- 19931.66B-1.0%
- 19921.67B-1.6%
- 19911.70B-1.4%
- 19901.72B-1.7%
- 19891.75B-2.0%
- 19881.79B-0.9%
- 19871.81B-3.0%
- 19861.86B+0.1%
- 19851.86B—
Shares Outstanding values are taken from Abbott Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's latest reported diluted shares outstanding is 1.75B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual diluted shares outstanding for Abbott Laboratories (ABT) came in at 1.75B – edged down 0.1% year-over-year.
Through 2020–2025 (5 years), Abbott Laboratories diluted shares outstanding delivered a -0.4% annualised rate; with a net decline across the window.
Abbott Laboratories diluted shares outstanding peaked at 1.86B in 1986; the latest annual figure is 1.75B in 2025 (6.3% below peak).
Across the available history, diluted shares outstanding reached its high of 1.86B in 1986 and its low of 1.48B in 2016.
Abbott Laboratories Shares Outstanding by Year
Abbott Laboratories Shares Outstanding 2025: 1.75B
In 2025, Abbott Laboratories reported diluted shares outstanding of 1.75B, edged down 0.1% below 2024.
Abbott Laboratories Shares Outstanding 2024: 1.75B
Abbott Laboratories diluted shares outstanding in 2024 was 1.75B, edged down 0.1% below 2023.
Abbott Laboratories Shares Outstanding 2023: 1.75B
2023's diluted shares outstanding for Abbott Laboratories came in at 1.75B, edged down 0.9% below 2022.
Abbott Laboratories Shares Outstanding 2022: 1.76B
Abbott Laboratories posted diluted shares outstanding of 1.76B in 2022, edged down 1.4% below 2021.
Abbott Laboratories Shares Outstanding 2021: 1.79B
Abbott Laboratories diluted shares outstanding in 2021 was 1.79B.
See more financial history for Abbott Laboratories (ABT).
Sector peers by Shares Outstanding
Healthcare peers of Abbott Laboratories (ABT), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation